- Treating pancreatic tumours may have revealed cancer’s master switch The Economist
- In Fight Against Pancreatic Cancer, Daraxonrasib Is Rare Sign Of Hope Forbes
- Georgia hospitals test ‘game-changer’ pancreatic cancer drugs AJC.com
- The Guardian view on cancer treatments: new hope for patients now and in the future | Editorial The Guardian
- Daraxonrasib’s Phase 3 Pancreatic Cancer Survival Data Might Change The Case For Investing In RVMD Yahoo Finance